目的：通过检测反复肺炎婴幼儿和健康婴幼儿血清中β-防御素-1（hBD-1）和免疫球蛋白A（IgA）、免疫球蛋白G（IgG）、免疫球蛋白M（IgM）浓度，探讨hBD-1和IgA、IgG、IgM在反复肺炎发病中的可能作用。方法：收集35例2~24月龄反复肺炎和35例健康婴幼儿的血清，处理后应用酶联免疫吸附法（ELISA）检测血清中hBD-1浓度，应用免疫比浊法测定血清IgA、IgG、IgM浓度，并分析血清hBD-1与IgA、IgG、IgM之间的相关性。结果：反复肺炎组血清hBD-1浓度为14±11 μg/mL，显著低于健康对照组（18±11 μg/mL），差异有统计学意义（P0.05）。结论：反复肺炎婴幼儿存在血清hBD-1、IgA、IgG水平低下的现象，提示呼吸道免疫防御功能存在障碍，这可能是婴幼儿反复肺炎的免疫因素之一；对反复肺炎婴幼儿同时检测 hBD-1、IgA、IgG、IgM具有重要的临床意义。
Abstract
OBJECTIVE: To study the possible role of human β-defensins 1 (Hbd-1) and immunoglobulins A, G and M (IgA, IgG and IgM) in the development of recurrent pneumonia by measuring serum concentrations of the above indexes in infants with recurrent pneumonia and healthy infants. METHODS: Serum samples were obtained from 35 healthy children and 35 children aged from 2 to 24 months with recurrent pneumonia. Serum Hbd-1 concentration was measured using ELISA. Serum IgA, IgG and IgM concentrations were measured by immunonephelometry. The correlation of hBD-1 with IgA, IgG and IgM was evaluated. RESULTS: The serum concentration of hBD-1 in infants with recurrent pneumonia (14±11 μg/mL) was significantly lower than in controls (18±11 μg/mL) (P0.05). CONCLUSIONS: The serum levels of hBD-1, IgA and IgG decrease in infants with recurrent pneumonia, suggesting disorders in the immune defensive function of the respiratory tract, and this may be one of the immunity related reasons for recurrent pneumonia in infants. It is of great clinical value to measure serum levels of Hbd-1, IgA, IgG and IgM in infants with recurrent pneumonia.
关键词
反复肺炎 /
β-防御素-1 /
免疫球蛋白 /
婴幼儿
Key words
Recurrent pneumonia /
Human β-defensins 1 /
Immunoglobulin /
Infant
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
［1］陈慧中，胡仪吉．如何认识反复呼吸道感染［J］．中华儿科杂志，2008，46（2）：83-84．
［2］胡仪吉.全国小儿呼吸道疾病学术会议纪要［J］．中华儿科杂志，1988，26（1）：41-42．
［3］韩瑞珠，郝艳艳，侯安存．反复呼吸道感染儿童细胞免疫与体液免疫［J］．实用儿科临床杂志，2007，26（10）：736-737．
［4］Prado Montes de Oca E. Human beta-defensin 1: a restless warrior against allergies, infections and cancer［J］. Int J Biochem Cell Biol, 2010, 42(6): 800-804.
［5］中华医学会儿科学会呼吸学组.儿童社区获得性肺炎管理指南（试行）（上）［J］.中华儿科杂志, 2007, 45(2): 83-90.
［6］中华医学会儿科学会呼吸学组.反复呼吸道感染的临床概念和处理原则［J］.中华儿科杂志, 2008, 46(2):108-110.
［7］Diamond G, Kaiser V, Rhodes J, Russell JP, Bevins CL. Transcriptional regulation of beta defensin gene expression in tracheal epithelial cells［J］. Infect Immun, 2000, 68(1):113-119.
［8］侯松萍，董震，潘留兰．卡介苗吸入对LPS致肺炎大鼠肺β-防御素mRNA的影响［J］.免疫学杂志, 2006, 22(5): 573-576.
［9］冯云，黄宁，吴琦，王伯徭．卡介苗胞壁蛋白诱导人肺腺上皮细胞hBD-1 mRNA表达及其抗菌活性的增强［J］. 中华微生物学和免疫学杂志，2001，21（4）：400-403.
［10］Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K, Keicho N. Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease［J］. Biochem Biophys Res Commun, 2002, 291(1): 17-22.
［11］都勇，孙书明，李玉．肿瘤坏死因子-a，人类β-防御索-1基因多态性与慢性阻塞性肺病相关性的研究［J］. 中国临床医学，2008，15：329-331．
［12］Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. Beta-defensin: linking innate and adaptive immunity through dendritic and T cell CCR6［J］. Science, 1999, 286(5439): 525-528.
［13］Yang D, Liu ZH, Tewary P, Chen Q, de la Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity［J］. Curr Pharm Des, 2007, 13(30): 3131-3139.
［14］胡学亭，李玉娟，李晓营，刘瑞文．肺炎支原体肺炎患儿补体及免疫球蛋白检测及临床分析［J］. 中国当代儿科杂志，2009，11（11）：933-934.
PDF(905 KB)
